admin, Author at PsyNews.com

Home Authors Posts by admin

2161 POSTS 0 COMMENTS

https://psynews.com

Real-World Data Reveals Variability in Access to, and Use of, Spravato

The ‘Nada Effect’: Why Psychedelics Don’t Work for Everyone

Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters

Pα+ Psychedelic Bulletin #172: Lykos Scales Back IIT Program, CEO Steps...

The Great Reconnector: Finding Our Way Back Together With Psychedelics

Breathwork, Holding Space, and the Healing Power of Connection: Documenting the...

Exclusive: David Hough on Lykos’ Path to Resubmission

Psychedelics and Addiction Recovery: Microdosing and Redefining the Path to Sobriety

Pα+ Psychedelic Bulletin #171: Lykos Criticises AdComm Process; Cybin’s Plan to...

Is Psychedelic-Assisted Therapy at a Crossroads? Exploring What’s Next for Lykos...

1...8910...217 Page 9 of 217

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special...

Natural Medicine Advisory Bulletin 15: A Duplicitous December

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin